Drilldown: Medicines
Use the filters below to narrow your results.
generic:
brand:
classes: (Click arrow to add another value)
mechanism:
None (1) ·
1-acetyl-LSD; prodrug of LSD (1) ·
5-HT2A agonist (26) ·
5-HT2A agonist; D2 partial agonist (1) ·
5-HT2A agonist; long duration (1) ·
5-HT2A agonist; MAO inhibitor (1) ·
5-HT2A agonist; milder than other 2C-x (1) ·
5-HT2A agonist; minor psilocybin mushroom alkaloid (1) ·
5-HT2A agonist; primarily auditory effects (1) ·
5-HT2A agonist; sigma-1 agonist (1) ·
5-HT2A partial agonist (1) ·
Contains bufotenin and DMT (1) ·
Contains LSA (2) ·
Contains mescaline (2) ·
Contains psilocybin and psilocin (1) ·
DMT + MAOI (harmine/harmaline); 5-HT2A agonist (1) ·
Extremely potent 5-HT2A agonist; vasoconstrictor (1) ·
Extremely potent 5-HT2A agonist; very long duration (1) ·
LSD analogue; 5-HT2A agonist (4) ·
Lysergic acid 2,4-dimethylazetidide; 5-HT2A agonist (1) ·
Lysergic acid hydroxyethylamide; 5-HT2A agonist (1) ·
Monoamine releasing agent; 5-HT2A agonist (1) ·
Potent 5-HT2A agonist (5) ·
Potent 5-HT2A agonist; no oral activity (1) ·
Potent 5-HT2A agonist; sigma-1 agonist (1) ·
Potent 5-HT2A agonist; very long duration (1) ·
Prodrug of 4-HO-DET; 5-HT2A agonist (1) ·
Prodrug of 4-HO-DiPT; 5-HT2A agonist (1) ·
Prodrug of 4-HO-MET; 5-HT2A agonist (1) ·
Prodrug of 4-HO-MiPT; 5-HT2A agonist (1) ·
Prodrug of LSD; 5-HT2A agonist (4) ·
Prodrug of psilocin; 5-HT2A agonist (1) ·
Serotonin/dopamine/norepinephrine releasing agent; 5-HT2A agonist (1) ·
Very potent 5-HT2A agonist; long duration (1) ·
'"`UNIQ--vote-00000E4A-QINU`"' The narrow safe-bolus window for IV use (sharp risk of arrhythmia, hypertensive emergency, intracerebral hemorrhage) is why anaphylaxis dosing is '''IM, not IV''', outside critical care'"`UNIQ--ref-00000E4B-QINU`"'. (1)
uses:
starting dose:
None (70) ·
15-37.5 mg PO once daily before breakfast or 1-2 hours after; Lomaira 8 mg TID (1) ·
Anaphylaxis IM 0.3-0.5 mg (adult) into lateral thigh, repeat q5-15 minutes prn; pediatric 0.01 mg/kg IM (max 0.3 mg, max 0.5 mg in adolescents); cardiac arrest 1 mg IV/IO q3-5 minutes; severe asthma neb 0.1 mg/kg up to 5 mg; never IV bolus for anaphylaxis outside critical care (1)
preparations:
routes:
onset:
duration:
halflife:
bioavailability:
pregnancy:
None (69) ·
Contraindicated in pregnancy.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1) ·
Not established (1) ·
Used in life-threatening obstetric anaphylaxis without hesitation; benefits clearly outweigh.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1)
Showing below up to 72 results in range #1 to #72.